SMi’s 6th annual Paediatric Clinical Trials held on 21st & 22nd March 2012, London

Paediatric vaccine development: Some key clinical trials - their design, execution and ethics
Spread the Word
Listed Under

Vaccine Development
Drug Development

• Pharmaceutical


Nov. 14, 2011 - PRLog -- Many drugs which are prescribed to children have not been adequately studied in the paediatric population. Pharmaceutical companies are now required to produce medicines specifically aimed at 0-17 year olds which has resulted in an increase in paediatric clinical trials. Trials in children are tightly regulated and have both operational and ethical challenges which need to be overcome.

Don’t miss out on this fantastic opportunity to network with experts in the field that includes:
Klaus Rose, Paediatric Drug Development Consultant, Klausrose Consulting
Lisa Moore-Ramdin, Senior Medical Advisor, Paediatric Vaccines, GlaxoSmithKline
Sabine Desset-Brethes, Project Leader, Pharmaceutical & Analytical Development, Novartis
Georg Schmitt, Head of Toxicology & NCS Paediatrics, F. Hoffman-La Roche
David McIntosh, Global Scientific Affairs Senior Expert, Novartis
Stephen Heaton, Head of Safety Risk Management Planning & Coordination, Bayer Healthcare
Thomas Hassall, Senior Director, Regulatory Policy & Intelligence, Abbott Laboratories
Ashley Strougo, Scientist, PK Modelling & Simulation, Astellas
Joseph Standing, Paediatric Clinical Lecturer, School of Pharmacy, University College London
Dirk Matthys, Head of Paediatrics, Ghent University Hospital
Hans Stoetter, Head of the Paediatric Working Group, Swissmedic

There will also be two interactive pre-conference workshops held on the 20th March, hosted by Gaynor Anders, Vice President/Head of Global Operations MMG and Klaus Rose – Managing Director Klausrose Consulting

For more information and to book your place visit
Alternatively, contact Andrew Gibbons at Tel: +44 (0)20 7827 6156 or Email:

# # #

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit
Source:SMi Group
Email:*** Email Verified
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. PRs
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share